In pathological settings, OPN frequently shows considerable increases and exhibits broad-spectrum actions in various inflammatory, autoimmune, degenerative, fibrotic, and oncologic disorders, including cancer, diabetes, stroke, kidney damage, and cardiac fibrosis [21]. The gene discussed is SPP1; the disease is cancer.